Division of Developmental Medicine, Boston Children's Hospital, Boston, MA.
Children's Hospital of Philadelphia, Philadelphia, PA.
J Dev Behav Pediatr. 2021 Aug 1;42(6):481-484. doi: 10.1097/DBP.0000000000000919.
To understand developmental-behavioral pediatricians' (DBPs') use of clinic versus telephone encounters for preschool attention-deficit/hyperactivity disorder (ADHD) medication management. Understanding use of telephone encounters for pharmacologic management of ADHD in preschoolers may inform care for children with ADHD.
DBP investigators within Developmental Behavioral Pediatrics Research Network abstracted data from medical records of 503 children aged younger than 72 months treated for ADHD with medication by a DBP clinician between January 1, 2013, and July 1, 2017, across 7 sites. We abstracted data about medication treatment episodes (defined as start and end/change of a specific type, dose, and frequency of ADHD medication) and encounter type (clinic vs telephone). We present descriptive statistics related to encounter types and χ2 analyses to compare frequencies across reasons for the end of treatment episode and across sites.
The study included 503 participants with a total of 1734 treatment episodes. The initial medication was started via a clinic encounter 85.9% of the time and via telephone encounters 14.1% of the time. When evaluating reasons for end of treatment episode, decreases in dose/frequency of medication were less common for clinic versus telephone encounters (27% vs 73%; p < 0.001) and adding an additional medication was more common at clinic versus telephone encounters (64% vs 36% p < 0.001). Sites varied significantly in frequency of telephone encounters, ranging from 16.9% to 68.9% (mean 45.7%).
Telephone encounters were used for pharmacologic management of ADHD in preschoolers to varying degrees across 7 DBP sites. These findings suggest that telephone management serves an important role in ADHD care.
了解发展行为儿科学(DBP)医生在小儿注意缺陷多动障碍(ADHD)药物管理中诊所与电话就诊的使用情况。了解学龄前儿童 ADHD 药物管理中电话就诊的使用情况,可能有助于 ADHD 儿童的护理。
发展行为儿科学研究网络的 DBP 研究人员从 2013 年 1 月 1 日至 2017 年 7 月 1 日期间,在 7 个地点,由 DBP 临床医生为 503 名年龄小于 72 个月的 ADHD 患儿用药物治疗的医疗记录中提取数据。我们提取了关于药物治疗(定义为开始和结束/改变特定类型、剂量和 ADHD 药物的频率)和就诊类型(诊所 vs 电话)的数据。我们介绍了与就诊类型相关的描述性统计数据,并进行了 χ2 分析,以比较治疗结束原因和各站点的就诊频率。
本研究共纳入 503 名参与者,共有 1734 次治疗发作。初始药物治疗 85.9%是在诊所就诊时开始的,14.1%是在电话就诊时开始的。在评估治疗结束的原因时,与诊所就诊相比,药物剂量/频率降低的情况在电话就诊中较少见(27% vs 73%;p < 0.001),而在诊所就诊中添加额外药物的情况更为常见(64% vs 36%;p < 0.001)。各站点间电话就诊的频率差异显著,范围为 16.9%至 68.9%(平均 45.7%)。
在 7 个 DBP 站点中,电话就诊在一定程度上用于小儿 ADHD 的药物管理。这些发现表明,电话管理在 ADHD 护理中起着重要作用。